Patent · US Active

Methods for programming differentiated cells into hematopoietic stem cells

US9540612B2 · kind B2 · utility

0Cited by
5References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 30, 2013
Grant dateJan 10, 2017
Priority date
Expiry dateJan 30, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure relates to the development of methods for making hematopoietic stem cells from differentiated cells by introducing and expressing transcription factors. More particularly, the disclosure provides methods for redirecting differentiated cells to a hematopoietic stem cell state or to a hemogenic endothelial cell state by direct programming with specific combinations of transcription factors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.